Overview of Dr. Danila
Dr. Daniel Danila is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from Carol Davila University of Medicine and Pharmacy and has been in practice 21 years. Dr. Danila accepts several types of health insurance, listed below. He is one of 497 doctors at Memorial Sloan Kettering Cancer Center and one of 89 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Oncology. He has more than 80 publications and over 500 citings.
Office
353 East 68th Street
New York, NY 10065
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2005 - 2009
Massachusetts General HospitalResidency, Internal Medicine, 2002 - 2005
Carol Davila University of Medicine and PharmacyClass of 1996
Certifications & Licensure
FL State Medical License 2021 - Present
CT State Medical License 2023 - 2026
NY State Medical License 2005 - 2026
NJ State Medical License 2018 - 2025
NC State Medical License 2020 - 2022
MA State Medical License 2004 - 2019- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer Start of enrollment: 2011 Mar 01
- Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate Cancer Start of enrollment: 2012 Sep 01
Publications & Presentations
PubMed
- 1 citationsMicrosatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer.Andrew T Lenis, Vignesh Ravichandran, Samantha Brown, Syed M Alam, Andrew Katims
Clinical Cancer Research. 2024-09-03 - Clinical, Imaging, and Technical Factors Associated with Successful Genomic Profiling of Bone Biopsy Tissue in Prostate Cancer.Fourat Ridouani, H Alberto Vargas, Daniel J Holzwanger, Heiko Schöder, Emily Waters
European Urology Oncology. 2024-08-01 - 2 citationsThe Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide.Susan Halabi, Siyuan Guo, Joseph J Park, David M Nanus, Daniel J George
Clinical Cancer Research. 2024-03-15
Professional Memberships
- Member
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Cofinity PPO
Empire BCBS HMO
Empire BCBS PPO
First Health PPO
GHI PPOGreat West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
PriorityHealth HMO
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
